Rise of geriatric population is expected to increase demand for global prolotherapy market during the forecast period. The increasing rate of diagnosis and treatment adoption rate is expected to increase demand for global prolotherapy market during the forecast period. Changing lifestyle and increasing prevalence of obesity will boost global prolotherapy market growth.
Advancement in technology, as well as rise in research and development, is expected to increase investments in global prolotherapy market are the favourable scenarios. For instance, in February 2016 Aurobindo Pharma final approval from the U.S. Food and Drug Administration (FDA) for manufacturing and commercialization of its Dextrose injection in the market.
Side effects of prolotherapy like infection or needle stick injuries are expected to hinder global prolotherapy market growth. Whereas, less adoption of prolotherapy in underdeveloped countries will challenge global prolotherapy market growth during the forecast period.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32457
The global prolotherapy market is classified based injectable, application, indication, end-users and region.
Based on the injectable, the global prolotherapy market is segmented into the following:
- Dextrose
- Platelet Rich Plasma
- Bicellular prolo
Based on the application, the global prolotherapy market is segmented into the following:
- Joint injection prolotherapy
- Ligament prolotherapy
- Tendon reconstruction prolotherapy
Based on the indication, the global prolotherapy market is segmented into the following:
- Lower back pain
- Neck pain
- Shoulder pain
- Knee pain
- Elbow pain
- Foot pain
- Plantar fasciitis
- Ankle pain
- Osteoarthritis
- Other musculoskeletal pain or injury
Based on the end-users, the global prolotherapy market is segmented into the following:
- Hospitals
- Ambulatory Care Centers
- Orthopedic Centres
- Speciality Clinics
- Academic and Research Institutes
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32457
- Pfizer Inc.
- Baxter International
- B. Braun
- Johnson & Johnson
- Arthex Inc.
- Terumo Corporation
- Aurobindo Pharma
- Shandong Qidu Pharmaceuticals
- Amphastar Pharmaceuticals Inc.
- Sanctus drugs & Pharmaceuticals
- Hospira Pharmaceutical Company
- Others
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com